The findings of this study demonstrated that alterations in AIF-1 were not ubiquitous, with the most frequently affected cancer type being lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), with over 8% of DLBC patients exhibiting alterations, mainly in the form of deep deletions. The gene discussed is AIF1; the disease is lymphoid neoplasm.